Prostate cancer 2000

Prostate Cancer and Prostatic Diseases

Volumn 3, Issue 4, 2000, Pages 218-223

  Bodmer, W F ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROSTATE SPECIFIC ANTIGEN; PROTEIN P53; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; TYROSINE KINASE RECEPTOR; VASCULOTROPIN;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SCREENING; CELL CYCLE; GENE MUTATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; RAT; TUMOR SUPPRESSOR GENE;

EID: 0034500748     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500485     Document Type: Article

References (17)

1. Failure of programmed cell death and differentiation as causes of tumor: Some simple mathematical models
2. In vitro human cell culture models for the study of prostate cancer
3. Androgens and growth factors in prostate cancer: A transgenic perspective
4. High risk genes predisposing to prostate cancer development - Do they exist?
5. The APC variants I1307K and E1317Q are associated with colorectal tumours, but not always with a family history
6. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q
7. Targeted screening for prostate cancer in African-American men
8. Association of missence substitution in SRDA5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA
9. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer
10. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells
11. The mutation rate and cancer
12. Anti-EGF receptor therapy
13. p53 website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis
14. Familial adenomatous polyposis (FAP) and its gene, APC
15. Bone morphogenetic protein-6: Potential mediator of osteoblastic metastases in prostate cancer
16. Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer
17. The immunotherapy of prostate cancer